Athena Philis-Tsimikas

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Randomized Controlled Trial

Glycemic Control

Top Venues

Diabetes, obesity & metabolism

Journal of diabetes science and technology

Diabetes technology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Harpreet S Bajaj, Björg Ásbjörnsdóttir, Lisbeth Carstensen, Christian Laugesen, Chantal Mathieu, Athena Philis-Tsimikas, Tadej Battelino
Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4. Diabetes care 47 (4) (2024)
Harpreet S Bajaj, Björg Ásbjörnsdóttir, Lisbeth Carstensen, Christian Laugesen, Chantal Mathieu, Athena Philis-Tsimikas, Tadej Battelino
Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4. Diabetes care 47 (4) (2024)
Harpreet S Bajaj, Björg Ásbjörnsdóttir, Lisbeth Carstensen, Christian Laugesen, Chantal Mathieu, Athena Philis-Tsimikas, Tadej Battelino
Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-Standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4. Diabetes care (2024)
Harpreet S Bajaj, Björg Ásbjörnsdóttir, Lisbeth Carstensen, Christian Laugesen, Chantal Mathieu, Athena Philis-Tsimikas, Tadej Battelino
Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4. Diabetes care 47 (4) (2024)
Harpreet S Bajaj, Björg Ásbjörnsdóttir, Lisbeth Carstensen, Christian Laugesen, Chantal Mathieu, Athena Philis-Tsimikas, Tadej Battelino
Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4. Diabetes care 47 (4) (2024)
Athena Philis-Tsimikas, Vanita R Aroda, Christophe De Block, Liana K Billings, Andreas Liebl, Ramsathish Sivarathinasami, John M D'Cruz, Ildiko Lingvay
Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes. Journal of diabetes science and technology (2023)
David C Klonoff, Jing Wang, David Rodbard, Michael A Kohn, Chengdong Li, Dorian Liepmann, David C Klonoff, David T Ahn, Anne L Peters, Guillermo E Umpierrez, Jane Jefferie Seley, Nicole Y Xu, Kevin T Nguyen, Gregg D Simonson, Michael S D Agus, Mohammed E Al-Sofiani, Gustavo Armaiz-Pena, Timothy S Bailey, Ananda Basu, Tadej Battelino, Sewagegn Yeshiwas Bekele, Pierre Yves Benhamou, B Wayne Bequette, Thomas Blevins, Marc D Breton, Jessica R Castle, James Geoffrey Chase, Kong Y Chen, Pratik Choudhary, Mark A Clements, Kelly L Close, Curtiss B Cook, Thomas Danne, Francis J Doyle Iii, Andjela T Drincic, Kathleen M Dungan, Steven V Edelman, Niels Ejskjær, Juan C Espinoza, G Alexander Fleming, Gregory P Forlenza, Guido Freckmann, Rodolfo J Galindo, Ana Maria Gómez, Hanna A Gutow, Lutz Heinemann, Irl B Hirsch, Thanh Duc Hoang, Roman Hovorka, Johan H Jendle, Li-Nong Ji, Shashank R Joshi, Michael Joubert, Suneil K Koliwad, Rayhan A Lal, M Cecilia Lansang, Wei-An Andy Lee, Lalantha Leelarathna, Lawrence Alan Leiter, Marcus Lind, Michelle L Litchman, Julia Katharina Mader, Katherine M Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Nicolas Mathioudakis, Alexander Y Mayorov, Jordan Messler, Joshua D Miller, Viswanathan Mohan, James H Nichols, Kirsten Nørgaard, David Norman O'Neal, Francisco J Pasquel, Athena Philis-Tsimikas, Thomas R Pieber, Moshe Phillip, William H Polonsky, Pradipta R Ray, Gerry Rayman, Eun Jung Rhee, Steven J Russell, Viral N Shah, Jennifer L Sherr, Koji Sode, Elias K Spanakis, Deborah J Wake, Kayo Waki, Amisha Wallia, Melissa E Weinberg, Howard Wolpert, Eugene E Wright, Mihail Zilbermint, Boris P Kovatchev
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings. Journal of diabetes science and technology (2022)
Kellee M Miller, Lauren G Kanapka, Michael R Rickels, Andrew J Ahmann, Grazia Aleppo, Lynn Ang, Anuj Bhargava, Bruce W Bode, Anders Carlson, Naomi S Chaytor, Gail Gannon, Robin Goland, Irl B Hirsch, Lisa Kiblinger, Davida Kruger, Yogish C Kudva, Carol J Levy, Janet B McGill, Grenye O'Malley, Anne L Peters, Louis H Philipson, Athena Philis-Tsimikas, Rodica Pop-Busui, Maamoun Salam, Viral N Shah, Michael J Thompson, Francesco Vendrame, Alandra Verdejo, Tracey D Brown, Laura Young, Richard Pratley
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes. Diabetes technology & therapeutics 24 (6) (2022)
Athena Philis-Tsimikas, Addie L Fortmann, Job G Godino, James Schultz, Scott C Roesch, Todd P Gilmer, Emilia Farcas, Haley Sandoval, Kimberly L Savin, Taylor Clark, Mariya Chichmarenko, Jennifer A Jones, Linda C Gallo
Dulce Digital-Me: protocol for a randomized controlled trial of an adaptive mHealth intervention for underserved Hispanics with diabetes. Trials 23 (1) (2022)
Athena Philis-Tsimikas, Harpreet S Bajaj, Kamilla Begtrup, Roman Cailleteau, Amoolya Gowda, Ildiko Lingvay, Chantal Mathieu, David L Russell-Jones, Julio Rosenstock
Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes. Diabetes, obesity & metabolism (2022)
Athena Philis-Tsimikas, David C Klonoff, Kamlesh Khunti, Harpreet S Bajaj, Lawrence A Leiter, Melissa V Hansen, Lone N Troelsen, Steen Ladelund, Simon Heller, Thomas R Pieber, null null
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial. Diabetologia 63 (4) (2020)
Athena Philis-Tsimikas, Wendy Lane, Ulrik Pedersen-Bjergaard, Carol H Wysham, Lars Bardtrum, Signe Harring, Simon R Heller
The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mL. Diabetes, obesity & metabolism 22 (5) (2020)
Addie L Fortmann, Samantha R Spierling Bagsic, Laura Talavera, Isabel Maria Garcia, Haley Sandoval, Amiry Hottinger, Athena Philis-Tsimikas
Glucose as the Fifth Vital Sign: A Randomized Controlled Trial of Continuous Glucose Monitoring in a Non-ICU Hospital Setting. Diabetes care 43 (11) (2020)
Andrej Janez, Petra Őrsy, Karolina Stachlewska, Karen Salvesen-Sykes, Liana K Billings, Athena Philis-Tsimikas
Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase-4 inhibitors upon initiation of degludec/liraglutide therapy: A post hoc analysis of the DUAL II and DUAL IX trials. Diabetes, obesity & metabolism 22 (4) (2020)
Athena Philis-Tsimikas, Liana K Billings, Robert Busch, Cristobal Morales Portillo, Rakesh Sahay, Natalie Halladin, Sarah Eggert, Kamilla Begtrup, Stewart B Harris
Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add-on to sodium-glucose co-transporter-2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes. Diabetes, obesity & metabolism 21 (6) (2019)
Addie L Fortmann, Linda C Gallo, Maria Isabel Garcia, Mariam Taleb, Johanna A Euyoque, Taylor Clark, Jessica Skidmore, Monica Ruiz, Sapna Dharkar-Surber, James Schultz, Athena Philis-Tsimikas
Dulce Digital: An mHealth SMS-Based Intervention Improves Glycemic Control in Hispanics With Type 2 Diabetes. Diabetes care 40 (10) (2017)